ATE90791T1 - Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex. - Google Patents

Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.

Info

Publication number
ATE90791T1
ATE90791T1 AT90402399T AT90402399T ATE90791T1 AT E90791 T1 ATE90791 T1 AT E90791T1 AT 90402399 T AT90402399 T AT 90402399T AT 90402399 T AT90402399 T AT 90402399T AT E90791 T1 ATE90791 T1 AT E90791T1
Authority
AT
Austria
Prior art keywords
diseases related
brain diseases
detecting brain
sclerosis multiplex
nervous cord
Prior art date
Application number
AT90402399T
Other languages
English (en)
Inventor
Jean-Pierre Zanetta
Jean-Marie Warter
Sabine Kuchler
Guy Vincendon
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE90791T1 publication Critical patent/ATE90791T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Air Bags (AREA)
  • Valve Device For Special Equipments (AREA)
  • Steering-Linkage Mechanisms And Four-Wheel Steering (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ignition Installations For Internal Combustion Engines (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT90402399T 1989-09-06 1990-08-30 Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex. ATE90791T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8911667A FR2651581B1 (fr) 1989-09-06 1989-09-06 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.
PCT/FR1990/000638 WO1991003737A1 (fr) 1989-09-06 1990-08-30 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques

Publications (1)

Publication Number Publication Date
ATE90791T1 true ATE90791T1 (de) 1993-07-15

Family

ID=9385190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90402399T ATE90791T1 (de) 1989-09-06 1990-08-30 Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.

Country Status (14)

Country Link
US (1) US5225352A (de)
EP (1) EP0416984B1 (de)
JP (1) JP3032290B2 (de)
AT (1) ATE90791T1 (de)
AU (1) AU648516B2 (de)
CA (1) CA2024731A1 (de)
DE (1) DE69001972T2 (de)
DK (1) DK0416984T3 (de)
ES (1) ES2057476T3 (de)
FI (1) FI921009A7 (de)
FR (1) FR2651581B1 (de)
IE (1) IE64042B1 (de)
NO (1) NO920852D0 (de)
WO (1) WO1991003737A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679034A1 (fr) * 1991-07-10 1993-01-15 Centre Nat Rech Scient Determination de la malignite des cellules de tumeurs humaines ou animales, au moyen de lectines endogenes.
FR2689520B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
NZ279855A (en) * 1994-02-04 1998-05-27 Bio Merieux Msrv1 and msrv2 pathogenic and/or infectious agents associated with ms, nucleic acids encoding them and diagnostic and therapeutic applications
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
FR2737500B1 (fr) 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
WO1998023755A1 (en) * 1996-11-26 1998-06-04 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
JPH11143616A (ja) 1997-11-10 1999-05-28 Sega Enterp Ltd 文字通信装置
WO2000007602A1 (en) * 1998-08-06 2000-02-17 The Johns Hopkins University School Of Medicine Compounds for altering cell surface sialic acids and methods of use therefor
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
US6660026B2 (en) 2000-10-05 2003-12-09 Seacoast Technologies, Inc. Multi-tipped cooling probe
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
WO2004034031A2 (en) * 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US6947870B2 (en) * 2003-08-18 2005-09-20 Baker Hughes Incorporated Neural network model for electric submersible pump system
FI20155280A7 (fi) 2015-04-15 2016-10-16 Medicortex Finland Oy Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
FR2618439B1 (fr) * 1987-07-21 1990-05-25 Strosberg Arthur Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
AU632474B2 (en) * 1988-04-14 1993-01-07 Incyte Pharmaceuticals, Inc. 14-beta-gal mammalian lectins

Also Published As

Publication number Publication date
FI921009A0 (fi) 1992-03-06
FR2651581B1 (fr) 1994-05-13
US5225352A (en) 1993-07-06
IE64042B1 (en) 1995-06-28
EP0416984B1 (de) 1993-06-16
JPH05500858A (ja) 1993-02-18
DE69001972D1 (de) 1993-07-22
DE69001972T2 (de) 1993-09-23
JP3032290B2 (ja) 2000-04-10
EP0416984A1 (de) 1991-03-13
IE903190A1 (en) 1991-03-13
FI921009A7 (fi) 1992-03-06
WO1991003737A1 (fr) 1991-03-21
CA2024731A1 (fr) 1991-03-07
ES2057476T3 (es) 1994-10-16
NO920852L (no) 1992-03-04
AU648516B2 (en) 1994-04-28
NO920852D0 (no) 1992-03-04
DK0416984T3 (da) 1993-08-16
FR2651581A1 (fr) 1991-03-08
AU6421490A (en) 1991-04-08

Similar Documents

Publication Publication Date Title
ATE90791T1 (de) Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.
TR24305A (tr) Blok kopolimer, bunu yapma metodu, bunun diamin oencueleri, bu tip diaminleri yapm
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
DE69129302D1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
NO904291D0 (no) Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.
IL119149A0 (en) A screening method for identifying ligands for target proteins
NO903449D0 (no) Fremgangsmaate for aa behandle underjordiske formasjoner.
SE8403630L (sv) Humana proteiner
BR9006977A (pt) Emulsao de aglutinante betuminoso de viscosidade controlada pela adicao de escleroglicano
NO904292D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
DE69016071D1 (de) Verfahren zur Augen-Diagnostik.
DE69015372D1 (de) Protein-testverfahren.
ATE86651T1 (de) Nichtalkalisches suessen von kohlenwasserstofffraktionen.
IT8921128A0 (it) Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano.
NO894880L (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
BR9007738A (pt) Metodo de tratamento de couros
IT8321550A0 (it) Procedimento per la concia delle pelli.
FI844645A0 (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
BR8304513A (pt) Composto,processo para sua preparacao,e fibra de poliester ou poliamida
NO951679D0 (no) Fibronektin-bindende protein, samt fremstilling derav
DE69009592D1 (de) Vorrichtung zur gegenseitigen Ausrichtung von verschieden farbigen Strahlbündeln und Visiereinrichtung, die diese Vorrichtung enthält.
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
PT8143Y (pt) Fitinha para solas de sapatos de juta ou canhamo
ES2085926T3 (es) Procedimiento para la determinacion del factor de von willebrand.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee